The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Fusion Protein Eye Injections Market Research Report 2025
Synopsis
Fusion protein eye injection is a fusion protein anti-VEGF drug used for ophthalmic treatment, including aflibercept injection and conbercept injection.
The global Fusion Protein Eye Injections market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Fusion Protein Eye Injections is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Fusion Protein Eye Injections is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Fusion Protein Eye Injections include Regeneron Pharmaceuticals (Eylea), Chengdu Kanghong Pharmaceutical, Qilu Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Fusion Protein Eye Injections, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fusion Protein Eye Injections.
The Fusion Protein Eye Injections market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Fusion Protein Eye Injections market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fusion Protein Eye Injections manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Regeneron Pharmaceuticals (Eylea)
Chengdu Kanghong Pharmaceutical
Qilu Pharmaceutical
Segment by Type
Aflibercept Injection
Conbercept Injection
Segment by Application
Macular Degeneration
Macular Edema
Uveitis
Retinal Vein Occlusion
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Fusion Protein Eye Injections manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Fusion Protein Eye Injections in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Fusion protein eye injection is a fusion protein anti-VEGF drug used for ophthalmic treatment, including aflibercept injection and conbercept injection.
The global Fusion Protein Eye Injections market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Fusion Protein Eye Injections is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Fusion Protein Eye Injections is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Fusion Protein Eye Injections include Regeneron Pharmaceuticals (Eylea), Chengdu Kanghong Pharmaceutical, Qilu Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Fusion Protein Eye Injections, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fusion Protein Eye Injections.
The Fusion Protein Eye Injections market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Fusion Protein Eye Injections market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fusion Protein Eye Injections manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Regeneron Pharmaceuticals (Eylea)
Chengdu Kanghong Pharmaceutical
Qilu Pharmaceutical
Segment by Type
Aflibercept Injection
Conbercept Injection
Segment by Application
Macular Degeneration
Macular Edema
Uveitis
Retinal Vein Occlusion
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Fusion Protein Eye Injections manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Fusion Protein Eye Injections in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Fusion Protein Eye Injections Market Overview
1.1 Product Definition
1.2 Fusion Protein Eye Injections by Type
1.2.1 Global Fusion Protein Eye Injections Market Value Comparison by Type (2024-2030)
1.2.2 Aflibercept Injection
1.2.3 Conbercept Injection
1.3 Fusion Protein Eye Injections by Application
1.3.1 Global Fusion Protein Eye Injections Market Value by Application (2024-2030)
1.3.2 Macular Degeneration
1.3.3 Macular Edema
1.3.4 Uveitis
1.3.5 Retinal Vein Occlusion
1.3.6 Others
1.4 Global Fusion Protein Eye Injections Market Size Estimates and Forecasts
1.4.1 Global Fusion Protein Eye Injections Revenue 2019-2030
1.4.2 Global Fusion Protein Eye Injections Sales 2019-2030
1.4.3 Global Fusion Protein Eye Injections Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Fusion Protein Eye Injections Market Competition by Manufacturers
2.1 Global Fusion Protein Eye Injections Sales Market Share by Manufacturers (2019-2024)
2.2 Global Fusion Protein Eye Injections Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Fusion Protein Eye Injections Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Fusion Protein Eye Injections, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Fusion Protein Eye Injections, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Fusion Protein Eye Injections, Product Type & Application
2.7 Global Key Manufacturers of Fusion Protein Eye Injections, Date of Enter into This Industry
2.8 Global Fusion Protein Eye Injections Market Competitive Situation and Trends
2.8.1 Global Fusion Protein Eye Injections Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Fusion Protein Eye Injections Players Market Share by Revenue
2.8.3 Global Fusion Protein Eye Injections Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Fusion Protein Eye Injections Market Scenario by Region
3.1 Global Fusion Protein Eye Injections Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Fusion Protein Eye Injections Sales by Region: 2019-2030
3.2.1 Global Fusion Protein Eye Injections Sales by Region: 2019-2024
3.2.2 Global Fusion Protein Eye Injections Sales by Region: 2025-2030
3.3 Global Fusion Protein Eye Injections Revenue by Region: 2019-2030
3.3.1 Global Fusion Protein Eye Injections Revenue by Region: 2019-2024
3.3.2 Global Fusion Protein Eye Injections Revenue by Region: 2025-2030
3.4 North America Fusion Protein Eye Injections Market Facts & Figures by Country
3.4.1 North America Fusion Protein Eye Injections Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Fusion Protein Eye Injections Sales by Country (2019-2030)
3.4.3 North America Fusion Protein Eye Injections Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Fusion Protein Eye Injections Market Facts & Figures by Country
3.5.1 Europe Fusion Protein Eye Injections Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Fusion Protein Eye Injections Sales by Country (2019-2030)
3.5.3 Europe Fusion Protein Eye Injections Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Fusion Protein Eye Injections Market Facts & Figures by Region
3.6.1 Asia Pacific Fusion Protein Eye Injections Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Fusion Protein Eye Injections Sales by Region (2019-2030)
3.6.3 Asia Pacific Fusion Protein Eye Injections Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Fusion Protein Eye Injections Market Facts & Figures by Country
3.7.1 Latin America Fusion Protein Eye Injections Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Fusion Protein Eye Injections Sales by Country (2019-2030)
3.7.3 Latin America Fusion Protein Eye Injections Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Fusion Protein Eye Injections Market Facts & Figures by Country
3.8.1 Middle East and Africa Fusion Protein Eye Injections Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Fusion Protein Eye Injections Sales by Country (2019-2030)
3.8.3 Middle East and Africa Fusion Protein Eye Injections Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Fusion Protein Eye Injections Sales by Type (2019-2030)
4.1.1 Global Fusion Protein Eye Injections Sales by Type (2019-2024)
4.1.2 Global Fusion Protein Eye Injections Sales by Type (2025-2030)
4.1.3 Global Fusion Protein Eye Injections Sales Market Share by Type (2019-2030)
4.2 Global Fusion Protein Eye Injections Revenue by Type (2019-2030)
4.2.1 Global Fusion Protein Eye Injections Revenue by Type (2019-2024)
4.2.2 Global Fusion Protein Eye Injections Revenue by Type (2025-2030)
4.2.3 Global Fusion Protein Eye Injections Revenue Market Share by Type (2019-2030)
4.3 Global Fusion Protein Eye Injections Price by Type (2019-2030)
5 Segment by Application
5.1 Global Fusion Protein Eye Injections Sales by Application (2019-2030)
5.1.1 Global Fusion Protein Eye Injections Sales by Application (2019-2024)
5.1.2 Global Fusion Protein Eye Injections Sales by Application (2025-2030)
5.1.3 Global Fusion Protein Eye Injections Sales Market Share by Application (2019-2030)
5.2 Global Fusion Protein Eye Injections Revenue by Application (2019-2030)
5.2.1 Global Fusion Protein Eye Injections Revenue by Application (2019-2024)
5.2.2 Global Fusion Protein Eye Injections Revenue by Application (2025-2030)
5.2.3 Global Fusion Protein Eye Injections Revenue Market Share by Application (2019-2030)
5.3 Global Fusion Protein Eye Injections Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Regeneron Pharmaceuticals (Eylea)
6.1.1 Regeneron Pharmaceuticals (Eylea) Company Information
6.1.2 Regeneron Pharmaceuticals (Eylea) Description and Business Overview
6.1.3 Regeneron Pharmaceuticals (Eylea) Fusion Protein Eye Injections Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Regeneron Pharmaceuticals (Eylea) Fusion Protein Eye Injections Product Portfolio
6.1.5 Regeneron Pharmaceuticals (Eylea) Recent Developments/Updates
6.2 Chengdu Kanghong Pharmaceutical
6.2.1 Chengdu Kanghong Pharmaceutical Company Information
6.2.2 Chengdu Kanghong Pharmaceutical Description and Business Overview
6.2.3 Chengdu Kanghong Pharmaceutical Fusion Protein Eye Injections Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Chengdu Kanghong Pharmaceutical Fusion Protein Eye Injections Product Portfolio
6.2.5 Chengdu Kanghong Pharmaceutical Recent Developments/Updates
6.3 Qilu Pharmaceutical
6.3.1 Qilu Pharmaceutical Company Information
6.3.2 Qilu Pharmaceutical Description and Business Overview
6.3.3 Qilu Pharmaceutical Fusion Protein Eye Injections Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Qilu Pharmaceutical Fusion Protein Eye Injections Product Portfolio
6.3.5 Qilu Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Fusion Protein Eye Injections Industry Chain Analysis
7.2 Fusion Protein Eye Injections Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Fusion Protein Eye Injections Production Mode & Process
7.4 Fusion Protein Eye Injections Sales and Marketing
7.4.1 Fusion Protein Eye Injections Sales Channels
7.4.2 Fusion Protein Eye Injections Distributors
7.5 Fusion Protein Eye Injections Customers
8 Fusion Protein Eye Injections Market Dynamics
8.1 Fusion Protein Eye Injections Industry Trends
8.2 Fusion Protein Eye Injections Market Drivers
8.3 Fusion Protein Eye Injections Market Challenges
8.4 Fusion Protein Eye Injections Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Fusion Protein Eye Injections Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Fusion Protein Eye Injections Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Fusion Protein Eye Injections Market Competitive Situation by Manufacturers in 2023
Table 4. Global Fusion Protein Eye Injections Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Fusion Protein Eye Injections Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Fusion Protein Eye Injections Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Fusion Protein Eye Injections Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Fusion Protein Eye Injections Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Fusion Protein Eye Injections, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Fusion Protein Eye Injections, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Fusion Protein Eye Injections, Product Type & Application
Table 12. Global Key Manufacturers of Fusion Protein Eye Injections, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Fusion Protein Eye Injections by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fusion Protein Eye Injections as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Fusion Protein Eye Injections Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Fusion Protein Eye Injections Sales by Region (2019-2024) & (K Units)
Table 18. Global Fusion Protein Eye Injections Sales Market Share by Region (2019-2024)
Table 19. Global Fusion Protein Eye Injections Sales by Region (2025-2030) & (K Units)
Table 20. Global Fusion Protein Eye Injections Sales Market Share by Region (2025-2030)
Table 21. Global Fusion Protein Eye Injections Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Fusion Protein Eye Injections Revenue Market Share by Region (2019-2024)
Table 23. Global Fusion Protein Eye Injections Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Fusion Protein Eye Injections Revenue Market Share by Region (2025-2030)
Table 25. North America Fusion Protein Eye Injections Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Fusion Protein Eye Injections Sales by Country (2019-2024) & (K Units)
Table 27. North America Fusion Protein Eye Injections Sales by Country (2025-2030) & (K Units)
Table 28. North America Fusion Protein Eye Injections Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Fusion Protein Eye Injections Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Fusion Protein Eye Injections Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Fusion Protein Eye Injections Sales by Country (2019-2024) & (K Units)
Table 32. Europe Fusion Protein Eye Injections Sales by Country (2025-2030) & (K Units)
Table 33. Europe Fusion Protein Eye Injections Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Fusion Protein Eye Injections Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Fusion Protein Eye Injections Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Fusion Protein Eye Injections Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Fusion Protein Eye Injections Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Fusion Protein Eye Injections Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Fusion Protein Eye Injections Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Fusion Protein Eye Injections Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Fusion Protein Eye Injections Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Fusion Protein Eye Injections Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Fusion Protein Eye Injections Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Fusion Protein Eye Injections Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Fusion Protein Eye Injections Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Fusion Protein Eye Injections Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Fusion Protein Eye Injections Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Fusion Protein Eye Injections Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Fusion Protein Eye Injections Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Fusion Protein Eye Injections Sales (K Units) by Type (2019-2024)
Table 51. Global Fusion Protein Eye Injections Sales (K Units) by Type (2025-2030)
Table 52. Global Fusion Protein Eye Injections Sales Market Share by Type (2019-2024)
Table 53. Global Fusion Protein Eye Injections Sales Market Share by Type (2025-2030)
Table 54. Global Fusion Protein Eye Injections Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Fusion Protein Eye Injections Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Fusion Protein Eye Injections Revenue Market Share by Type (2019-2024)
Table 57. Global Fusion Protein Eye Injections Revenue Market Share by Type (2025-2030)
Table 58. Global Fusion Protein Eye Injections Price (US$/Unit) by Type (2019-2024)
Table 59. Global Fusion Protein Eye Injections Price (US$/Unit) by Type (2025-2030)
Table 60. Global Fusion Protein Eye Injections Sales (K Units) by Application (2019-2024)
Table 61. Global Fusion Protein Eye Injections Sales (K Units) by Application (2025-2030)
Table 62. Global Fusion Protein Eye Injections Sales Market Share by Application (2019-2024)
Table 63. Global Fusion Protein Eye Injections Sales Market Share by Application (2025-2030)
Table 64. Global Fusion Protein Eye Injections Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Fusion Protein Eye Injections Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Fusion Protein Eye Injections Revenue Market Share by Application (2019-2024)
Table 67. Global Fusion Protein Eye Injections Revenue Market Share by Application (2025-2030)
Table 68. Global Fusion Protein Eye Injections Price (US$/Unit) by Application (2019-2024)
Table 69. Global Fusion Protein Eye Injections Price (US$/Unit) by Application (2025-2030)
Table 70. Regeneron Pharmaceuticals (Eylea) Company Information
Table 71. Regeneron Pharmaceuticals (Eylea) Description and Business Overview
Table 72. Regeneron Pharmaceuticals (Eylea) Fusion Protein Eye Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Regeneron Pharmaceuticals (Eylea) Fusion Protein Eye Injections Product
Table 74. Regeneron Pharmaceuticals (Eylea) Recent Developments/Updates
Table 75. Chengdu Kanghong Pharmaceutical Company Information
Table 76. Chengdu Kanghong Pharmaceutical Description and Business Overview
Table 77. Chengdu Kanghong Pharmaceutical Fusion Protein Eye Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Chengdu Kanghong Pharmaceutical Fusion Protein Eye Injections Product
Table 79. Chengdu Kanghong Pharmaceutical Recent Developments/Updates
Table 80. Qilu Pharmaceutical Company Information
Table 81. Qilu Pharmaceutical Description and Business Overview
Table 82. Qilu Pharmaceutical Fusion Protein Eye Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Qilu Pharmaceutical Fusion Protein Eye Injections Product
Table 84. Qilu Pharmaceutical Recent Developments/Updates
Table 85. Key Raw Materials Lists
Table 86. Raw Materials Key Suppliers Lists
Table 87. Fusion Protein Eye Injections Distributors List
Table 88. Fusion Protein Eye Injections Customers List
Table 89. Fusion Protein Eye Injections Market Trends
Table 90. Fusion Protein Eye Injections Market Drivers
Table 91. Fusion Protein Eye Injections Market Challenges
Table 92. Fusion Protein Eye Injections Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
Table 96. Authors List of This Report
List of Figures
Figure 1. Product Picture of Fusion Protein Eye Injections
Figure 2. Global Fusion Protein Eye Injections Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Fusion Protein Eye Injections Market Share by Type: 2023 & 2030
Figure 4. Aflibercept Injection Product Picture
Figure 5. Conbercept Injection Product Picture
Figure 6. Global Fusion Protein Eye Injections Market Value by Application (2024-2030) & (US$ Million)
Figure 7. Global Fusion Protein Eye Injections Market Share by Application: 2023 & 2030
Figure 8. Macular Degeneration
Figure 9. Macular Edema
Figure 10. Uveitis
Figure 11. Retinal Vein Occlusion
Figure 12. Others
Figure 13. Global Fusion Protein Eye Injections Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Fusion Protein Eye Injections Market Size (2019-2030) & (US$ Million)
Figure 15. Global Fusion Protein Eye Injections Sales (2019-2030) & (K Units)
Figure 16. Global Fusion Protein Eye Injections Average Price (US$/Unit) & (2019-2030)
Figure 17. Fusion Protein Eye Injections Report Years Considered
Figure 18. Fusion Protein Eye Injections Sales Share by Manufacturers in 2023
Figure 19. Global Fusion Protein Eye Injections Revenue Share by Manufacturers in 2023
Figure 20. Global 5 and 10 Largest Fusion Protein Eye Injections Players: Market Share by Revenue in Fusion Protein Eye Injections in 2023
Figure 21. Fusion Protein Eye Injections Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 22. Global Fusion Protein Eye Injections Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Fusion Protein Eye Injections Sales Market Share by Country (2019-2030)
Figure 24. North America Fusion Protein Eye Injections Revenue Market Share by Country (2019-2030)
Figure 25. United States Fusion Protein Eye Injections Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Fusion Protein Eye Injections Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Fusion Protein Eye Injections Sales Market Share by Country (2019-2030)
Figure 28. Europe Fusion Protein Eye Injections Revenue Market Share by Country (2019-2030)
Figure 29. Germany Fusion Protein Eye Injections Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Fusion Protein Eye Injections Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Fusion Protein Eye Injections Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Fusion Protein Eye Injections Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Fusion Protein Eye Injections Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Fusion Protein Eye Injections Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Fusion Protein Eye Injections Revenue Market Share by Region (2019-2030)
Figure 36. China Fusion Protein Eye Injections Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Fusion Protein Eye Injections Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Fusion Protein Eye Injections Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Fusion Protein Eye Injections Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Fusion Protein Eye Injections Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Taiwan Fusion Protein Eye Injections Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Southeast Asia Fusion Protein Eye Injections Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Fusion Protein Eye Injections Sales Market Share by Country (2019-2030)
Figure 44. Mexico Fusion Protein Eye Injections Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Fusion Protein Eye Injections Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Fusion Protein Eye Injections Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Colombia Fusion Protein Eye Injections Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East and Africa Fusion Protein Eye Injections Sales Market Share by Country (2019-2030)
Figure 49. Middle East and Africa Fusion Protein Eye Injections Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Fusion Protein Eye Injections Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Fusion Protein Eye Injections Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Fusion Protein Eye Injections Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Fusion Protein Eye Injections by Type (2019-2030)
Figure 54. Global Revenue Market Share of Fusion Protein Eye Injections by Type (2019-2030)
Figure 55. Global Fusion Protein Eye Injections Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Fusion Protein Eye Injections by Application (2019-2030)
Figure 57. Global Revenue Market Share of Fusion Protein Eye Injections by Application (2019-2030)
Figure 58. Global Fusion Protein Eye Injections Price (US$/Unit) by Application (2019-2030)
Figure 59. Fusion Protein Eye Injections Value Chain
Figure 60. Fusion Protein Eye Injections Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
